Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Assembly Biosciences Q2 EPS $(0.55) Down From $0.19 YoY

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.55) per share. This is a 389.47 percent decrease over earnings of $0.19 per share from the same period last year.

byBenzinga Newsdesk

August 5, 2021

1 minute read

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.55) per share. This is a 389.47 percent decrease over earnings of $0.19 per share from the same period last year.

Earnings

Earnings Outlook For CIT Group

By Benzinga Insights

Today, 9:52 PM

On Tuesday, July 27, CIT Group (NYSE:CIT) will release its latest earnings report. Benzinga's outlook for CIT Group is included in the following report.

CIT

Jefferies Initiates Coverage On General Electric with Hold Rating, Announces Price Target of $100

By Benzinga Newsdesk

Today, 9:52 PM

Jefferies analyst Saree Boroditsky initiates coverage on General Electric (NYSE:GE) with a Hold rating and announces Price Target of $100.

Keybanc Maintains Overweight on Catalent, Lowers Price Target to $125

By Benzinga Newsdesk

Today, 9:52 PM

Keybanc analyst Paul Knight maintains Catalent (NYSE:CTLT) with a Overweight and lowers the price target from $155 to $125.

CTLT

Schnitzer Steel Industries: Debt Overview

By Benzinga Insights

Today, 9:52 PM

Over the past three months, shares of Schnitzer Steel Indus (NASDAQ:SCHN) increased by 7.02%. Before we understand the importance of debt, let us look at how much debt Schnitzer Steel Indus has.

SCHN

Assembly Biosciences Q2 EPS $(0.55) Down From $0.19 YoY

Related Posts

Earnings Outlook For CIT Group

Jefferies Initiates Coverage On General Electric with Hold Rating, Announces Price Target of $100

Keybanc Maintains Overweight on Catalent, Lowers Price Target to $125

Schnitzer Steel Industries: Debt Overview